SOMATOSTATIN RECEPTOR SCINTIGRAPHY USING [IN-111-DTPA(0)]RC-160 IN HUMANS - A COMPARISON WITH [IN-111-DTPA(0)]OCTREOTIDE

Citation
Wap. Breeman et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY USING [IN-111-DTPA(0)]RC-160 IN HUMANS - A COMPARISON WITH [IN-111-DTPA(0)]OCTREOTIDE, European journal of nuclear medicine, 25(2), 1998, pp. 182-186
Citations number
10
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
ISSN journal
03406997
Volume
25
Issue
2
Year of publication
1998
Pages
182 - 186
Database
ISI
SICI code
0340-6997(1998)25:2<182:SRSU[I>2.0.ZU;2-G
Abstract
Somatostatin receptor-positive lesions can be visualized by scintigrap hy using [In-111-DTPA(0)]octreotide, Recently, there have been reports of differences in receptor binding between somatostatin receptor subt ypes and between somatostatin analogues, such as RC-160 and octreotide , as well as of differences in internalization between the somatostati n receptor subtypes. The possibility that certain somatostatin recepto r-positive tissues and tumours which do not bind octreotide may bind a nd internalize RC-160 would open new; scintigraphic or radiotherapeuti c applications of radiolabelled RC-160. We investigated the metabolism and tissue distribution of [In-111-DTPA(0)]RC-160 in comparison with [In-111-DTPA(0)]octreotide in four patients after injection of 250 MBq (10 mu g) of these radiopharmaceuticals. Patient 1 had a metastatic f ollicular thyroid carcinoma, patient 2 a metastatic medullary thyroid carcinoma, patient 3 tuberculosis and patient 4 an insulinoma. The pla sma clearance of the [In-111-DTPA(0)]RC-160 was slower than that of [I n-111-DTPA(0)]octreotide, with 5% and 2%, respectively, of the initial plasma radioactivity remaining at 10 h p.i. The urinary excretion of [In-111-DTPA(0)]RC-160 was initially also slower than that of [In-111- DTPA(0)]octreotide, but the cumulative excretion of radioactivity was not significantly different at 48 h p.i. Approximately 80% of injected radioactivity was cleared in the urine, while in one patient 20% of t he injected dose was recovered in the faeces. The slower clearance of [In-111-DTPA(0)]RC-160 resulted in a higher background in all organs s tudied i.e. liver, spleen. kidneys and lungs, at 24 h p.i. Although th e target to background ratio with [In-111-DTPA(0)]octreotide was highe r, no differences were found between the two analogues with regard to their sensitivity in detecting lesions in these four patients, We conc lude that although only four subjects were studied, [In-111-DTPA(0)]RC -160 does not appear to have additional value for scintigraphy and is associated with higher background activity.